Abbvie Inc Patent Portfolio Statistics
Profile Summary
This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.
How does the overall patent portfolio of Abbvie Inc. look like?
| Assignee | Art Units | |
| Total Applications: | 1,731 | 1,870,395 |
| Granted Patents: | 1,302 | 1,006,108 |
| Grant Index | 78.29% ↑ | 67.94% |
| Abandoned/Rejected Applications: | 361 (21.71%) | 474,693 (32.06%) |
| In-Process Applications: | 66 | 389,594 |
| Average Grant Time: | 2.82 Years ↑ | 2.7 Years |
| Average Office Actions: | 1.52 ↓ | 1.63 |
Which Technology Area Abbvie Inc. is filing most patents in? (Last 10 years)
| Art Unit | Definition | Total Applications |
| 1626 | Organic Chemistry | 230 |
| 1624 | Organic Chemistry | 220 |
| 1625 | Organic Chemistry | 188 |
| 1644 | Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology | 79 |
| 1622 | Organic Chemistry | 70 |
How many patents are Abbvie Inc. filing every year?
| Year | Total Applications | Predicted |
| 2022 | 0* | 669 |
| 2021 | 12* | 613 |
| 2020 | 33 | 427 |
| 2019 | 41 | 41 |
| 2018 | 62 | – |
| 2017 | 62 | – |
| 2016 | 81 | – |
| 2015 | 113 | – |
| 2014 | 139 | – |
| 2013 | 120 | – |
*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published
Recently filed patent applications of Abbvie Inc. in USPTO?
Application number: PCT/US14/54888
Abstract:
–
Publication date: 2015-03-19
Applicant: Abbvie Inc.
Inventors: Gong Yuchuan
Publication number: 2014144935
Application number: PCT/US14/29547
Abstract:
–
Publication date: 2014-09-18
Applicant: Abbvie Inc.
Inventors: Akamatsu Yoshiko
How are Abbvie Inc.’s applications performing in USPTO?
| Application Number | Title | Status | Art Unit | Examiner |
| PCT/US14/54888 | Atrasentan Mandelate Salts | RO PROCESSING COMPLETED-PLACED IN STORAGE | 1629 | – |
| PCT/US14/29547 | Anti-Cd25 Antibodies And Their Uses | RO PROCESSING COMPLETED-PLACED IN STORAGE | 1643 | – |
